1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Analytical Tool - Protein Kinase Inhibitors in Oncology

Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2014*

The Package Includes
* A progress analysis on current and emerging drugs
* Information on most companies active in the development of PKIs in oncology
* Information on key industry related PKI drug projects in oncology
* Data from most important clinical trials
* Information on early developmental stage projects
* Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:
* Tracking cutting edge companies, therapies and new technologies
* Rapid identification of partners & competitors
* Laying down a comprehensive framework for further analysis of the field
* Producing presentations surrounding the development of PKI drugs in oncology
* Identifying emerging PKI cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of PKI drug development in cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Table Of Contents

Analytical Tool - Protein Kinase Inhibitors in Oncology

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Oncology Pathways in the US – Friend or Foe for Pharma?

Oncology Pathways in the US – Friend or Foe for Pharma?

  • $ 4 500
  • Industry report
  • July 2015
  • by Datamonitor Healthcare

The costs of treating cancer in the US are spiralling upward, and payers have taken notice This report takes a detailed look at the growing focus on value and quality that is driving greater use of clinical ...

Malignant Melanoma Pricing and Reimbursement

Malignant Melanoma Pricing and Reimbursement

  • $ 4 500
  • Industry report
  • September 2015
  • by Datamonitor Healthcare

With several new high cost melanoma drugs available, payer decisions on whether patients can access those drugs and under what conditions are becoming more important than ever This report covers both analysis ...

Liver Cancer - Pipeline Review, 2015

Liver Cancer - Pipeline Review, 2015

  • $ 4 000
  • Industry report
  • October 2015
  • by Global Data

Liver Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Liver Cancer - Pipeline Review, 2015" provides an overview of Liver Cancer diagnostic tests currently in pipeline ...

Melanoma - Pipeline Review, 2015

October 2015 $ 4 000

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.